View Article

  • Magnetic Nanomaterials for Biomedical and Pharmaceutical Applications: Fundamentals, Functionalization, and Therapeutic Potential

  • 1Asst. Prof., Smt Kashibai Navale College of Engineering, Pune, Maharashtra, India
    2Asst. Prof., Department of Sciences and Humanities, Kasegaon Education Societys Rajarambapu Institute of Technology, Sakharale, Islampur, Sangli, Maharashtra, India
     

Abstract

Magnetic nanomaterials have emerged as an important class of nanoscale materials with extensive potential in biomedical and pharmaceutical sciences owing to their unique magnetic responsiveness, tunable surface chemistry, and remarkable physicochemical characteristics. On the nanoscale, the magnetic substances behave quite differently as opposed to their bulk counterparts, such as superparamagnetism, high surface to volume ratio, and high magnetic susceptibility. The properties allow to precisely manipulate the magnetic nanoparticles with the help of external magnetic fields which in turn permit to integrate them into numerous therapeutic and diagnostic platforms. Magnetic nanoparticles that are iron oxide based like magnetite and maghemite have received significant interests because they are well biocompatible, display chemical stability and low toxicity and thus can be used in biomedical applications such as drug delivery, imaging, biosensing and hyperthermia based cancer therapy. Recent technological innovation in nanotechnology has made it possible to create versatile magnetic nanomaterials with customizable surface functionalization that permits targeting of particular tissues and cells. Biomolecules, polymers, and ligands Surface modification of magnetic nanoparticles greatly enhances colloidal stability, aggregation, and biological compatibility of nanoparticles in physiological conditions. Moreover, magnetic nanomaterials have also been extensively studied as contrast agents to magnetic resonance imaging, and magnetic guided delivery systems of drugs that allow controlled and site specific therapeutic delivery. Although the advancements observed in this area are encouraging, a number of issues such as aggregation of nanoparticles, possible cytotoxicity, inefficiency in targeting as well as regulatory challenges in clinical translation still exist. This review will give an in-depth analysis of the underlying principles and synthesis strategies, surface functionalization procedure, characterization procedure, biomedical uses, toxicity, and future outlook of magnetic nanomaterials in biomedical and pharmaceutical research.

Keywords

Magnetic nanoparticles ,Nanomedicine, Drug delivery, Magnetic hyperthermia, Magnetic resonance imaging, Surface functionalization, Biomedical nanotechnology

Introduction

Modern biomedical and pharmaceutical sciences have undergone a radical revolution brought about by nanotechnology that allows the design and production of materials at nanoscale with new physical, chemical and biological characteristics. Nanometer-engineered materials exhibit some of the most unusual properties that are not otherwise found in bulk materials because of quantum confinement, larger surface-area, and modified electronic structures. Such nanoscale properties have provided new possibilities in the development of new diagnostic apparatus, targeted therapeutic systems, and multifunctional biomedical apparatuses [1]. Magnetic nanomaterials are one of the various classes of nanomaterials that have attracted a lot of attention because they can respond to external magnetic fields and at the same time remain at nanoscale size that can be used in biological interactions. The magnetic nanomaterials can be widely defined as nanoparticles made of magnetic components or materials including iron, cobalt, nickel or their oxides and ferrites that have magnetic features when subjected to an external magnetic field. The reason behind this is the fact that these particles usually have sizes in the range of 1-100 nanometres hence can interact with biomolecules, cells and tissues in complex biological environments in a unique manner due to the distinctive physicochemical and magnetic characteristics that these materials develop with the nanoscale [2]. Superparamagnetic is one of the greatest properties of magnetic nanoparticles whereby nanoparticles are highly magnetized when an external magnetic field is applied upon the nanoparticles instead of magnetic remanence being maintained once the external magnetic field is removed. This property is especially beneficial in biomedical systems since it prevents the aggregation of the particles and provides colloidal stability in the physiological systems [3]. Moreover, due to high surface-volume ratio of nanoparticles, these particles can be easily functionalized on their surfaces with polymers, ligands and biomolecules, which improve their stability, targeting ability and other biological systems [4]. The magnetic nanomaterials have a few benefits over the traditional therapeutic and diagnostic materials, as well. They can be magnetically responsive, which means that external magnetic fields can direct nanoparticles to their target anatomic locations and thus create magnetically targeted drug delivery systems to decrease systemic toxicity and enhance therapeutic efficacy. Besides, magnetic nanoparticles may be used as contrast agents in a magnetic resonance imaging model, which offers increased sensitivity to image and spatial resolution in the diagnosis of disease [5]. They have also been applied in magnetic hyperthermia therapy wherein local heating of magnetic nanoparticles within the alternating magnetic fields can be used to selectively kill cancer cells without damaging the nearby healthy tissues [6]. Besides these, magnetic nanomaterials are also showing potentials in biosensing, bioseparation, tissue engineering, gene delivery and regenerative medicine. Their versatility enables them to be used in diagnostic and therapeutic applications on the same nanoscale platform and thus the creation of enhanced theranostic systems that enable disease diagnosis and targeted therapy in one platform [7]. The growing interdisciplinary research in the areas of materials science, nanotechnology, chemistry, biology, and medicine has boosted the creation of new magnetic nanomaterials with better physicochemical properties and improved biological activities. Nonetheless, even with these encouraging developments, various challenges are still present in regards to the stability of nanoparticles, possible toxicity, large scale production, and clinical approval of magnetic nanomaterials use [2,6].Accordingly, the key to successful translation of magnetic nanomaterials into clinical and pharmaceutical use is a thorough insight into the fundamentals of the concept, production methods, functionalization, characterization, and regulatory approval of nanomaterials use. This review aims at discussing in detail the basic principles of magnetism of the magnetic nanomaterials, the different types of magnetic nanoparticles employed in biomedical research, synthesis methods, surface engineering approaches, characterization of the nanoparticles and the different biomedical and pharmaceutical applications. Besides, the review also points out the aspects of toxicity, the limitations that are present, and the future trends in the development of magnetic nanomaterials in advanced medical practices.

Figure 1. Graphical diagram of the multifunctional biomedical uses of magnetic nanomaterials such as drug delivery, magnetic resonance imaging, biosensing and hyperthermia therapy.

The Figure 1. Publications that the biomedical multifunctional uses of magnetized nanomaterials. Magnetic nanoparticles are the flexible nanoplatforms, which can be used in magnetic guided drug delivery, in addition to contrast in magnetic resonance imaging (MRI), in sensitive biosensing and diagnostics, and in production of local heat in magnetic hyperthermia therapy of cancer.

2. Fundamental Principles Of Magnetic Nanomaterials

The magnetic nanomaterials are characterized by special magnetic properties which develop due to overall interaction of electrons and atomic magnetic moments within the Nano compositions. On smaller sizes, the magnetic properties are highly dependent on the size of the particles, morphology, crystal structure and surface effects. The basic magnetic concepts in magnetic nanomaterials must be understood so as to maximize the use of magnetic nanomaterials in biomedical and pharmaceutical applications including targeted drug delivery, imaging and magnetic hyperthermia therapy. The magnetic behaviour of nanoparticles is determined by parameters including magnetic moment, magnetization, susceptibility, coercivity, and anisotropy, all of which are significantly influenced by nanoscale phenomena and interparticle interactions [8]. Magnetic nanoparticles exhibit distinctive behaviour compared with bulk materials because of quantum confinement effects and the increasing dominance of surface atoms. When the particle size approaches the nanometre range, a large proportion of atoms reside at the surface, which significantly alters electronic structure and magnetic ordering. Such size dependent changes may frequently result in increased magnetic susceptibility, change in coercivity and the development of superparamagnetic behavior which is especially significant in biomedical use since superparamagnetic behavior eliminates magnetic remanence and reduces aggregation of the nanoparticles in physiological conditions [9].

2.1 Basic Concepts of Magnetism

The sources of magnetism are motion of electric charges and natural magnetic moment of electron spin and orbital angular momentum. The overall orientation of the atomic magnetic moments in these materials leads to the development of observable magnetic properties as in magnetic materials. The strength and orientation of a magnetic source are described by the magnetic moment and normally given in a form of a vector. On exposing magnetic nanoparticles to external magnetic field, the magnetic moments exhibit the alignment with the applied field and lead to magnetization of the material. Magnetization can be characterized as the measure of magnetic response of a substance in unit volumes and is the summation of the magnetic response of the substance when the substance is expounded to an external magnetic field. The extent of magnetization is determined by the makeup of the material, temperature and structural features of the nanoparticles. Magnetic susceptibility refers to the degree to which a substance is magnetized in an external magnetic field. Highly magnetic susceptible materials have high magnetic responses and hence are very desirable in biomedical processes that require magnetic manipulation and imaging [10]. The other important magnetic parameter is that of coercivity which is the ability of a magnetic material to resist demagnetization. High-coercivity materials maintain a high level of magnetization despite the loss of an exogenous field and low-coercivity materials de-magnetize quickly. Low-coercivity nanoparticles with superparamagnetic properties are desirable in biomedical biology since they do not exhibit undesired aggregation and magnetic interactions in the body [11]. Magnetic anisotropy is the dependence of magnetic characteristics in a substance in a directional manner. Magnetic anisotropy in nanoparticles is due to crystal structure, particle shape and surface effect. Large magnetic anisotropy helps to stabilize magnetic moments and affects the energy barrier to be overcome in order to reverse the magnetization. This aspect is very important in defining the magnetic relaxation behavior and heating efficiency of nanoparticles in magnetic hyperthermia therapy [12].

2.2 Types of Magnetic Behavior

There are a number of categories of the magnetic materials according to the position and interaction of the atomic magnetic moments. These are diamagnetism, paramagnetism, ferromagnetism, ferrimagnetism and superparamagnetism. The material is found to have particular electronic configurations and magnetic interactions that cause each kind of magnetic behavior. Diamagnetic materials are those that respond to magnetic forces with very low magnetic responds and create induced magnetic field which acts in the opposite direction of the applied magnetic field. The materials only have paired electrons and hence they do not have permanent magnetic moments. Even though, the effects of diamagnetism are usually weak, they contribute to the magnetic behavior of biological tissues and their immediate surroundings in biomedical imaging systems [8]. Unpaired electrons that give rise to the tiny magnetic moments are found in paramagnetic materials. These magnetic moments are partially aligned to the external magnetic field producing a weak positive magnetic susceptibility. This alignment is however disturbed by thermal energy when the external field is taken off leaving the magnetization to vanish. Ferromagnetic materials have a high magnetic interaction because of parallel alignment of the atomic magnetic moments by exchange interaction. It is this alignment that causes magnetic domains to form and causes it to be permanently magnetized even when the external magnetic field is removed. Despite the high magnetization levels of the ferromagnetic materials, there is a restriction of their application in biomedical applications owing to the risk of aggregation and the possibility of being toxic. Ferrimagnetism is a property of a material when magnetic moments are oriented opposite to each other but have unequal magnitudes and create a net magnetic moment. Magnetite and maghemite are iron oxide nanoparticles that behave like ferrimagnetic in bulk and find extensive application in the biomedical field because of their stability and high magnet response [13]. Superparamagnetism is a special magnetic phenomenon that occurs on a nanoscale and especially when the size of particles is smaller than a critical size which is usually a range of 20 nanometers. In this condition, every nanoparticle acts as one magnetic domain with a high magnetic moment. Thermal fluctuations cause rapid randomization of magnetic orientation in the absence of an external magnetic field, eliminating residual magnetization. This property is extremely advantageous in biomedical applications because it prevents particle aggregation and enables reversible magnetic manipulation using external magnetic fields [14]

Figure 2. Simulation of various magnetic properties such as diamagnetism, paramagnetism, ferromagnetism, ferrimagnetism and superparamagnetism that are found in magnetic nanomaterials.

Figure 2. The illustration of various magnetic behaviors in magnetic nanomaterials at an external magnetic field. The orientation of the magnetic moments of diamagnetism, paramagnetism, ferromagnetism, ferrimagnetism and superparamagnetism was represented using the diagram. Each of these behaviors is different in its spin arrangements and magnetic responses and affects the magnetic properties and biomedical performance of nanoscale materials significantly. Due to the size dependence of the magnetic properties, the magnetic performance of nanodispersions was studied among different materials and surfaces using unique geometries. The magnetic performance of nanodispersions between various materials and surfaces were investigated based on different geometries due to the size dependence of the magnetic properties. Nanoparticles are strongly affected by particle size, shape and surface structure to determine their magnetic properties. When the particle size drops to the nanometer level, there is a great change in the magnetic domain structures. In bulk ferromagnetic substances, different magnetic domains are present in order to reduce the magnetic energy. But at a small enough size of the particle the multi domain formation becomes energy prohibited leading to the single domain nanoparticles. Single domain nanoparticles have a homogenous magnetization of the particle, increased magnetic responsiveness is observed. Such nanoparticles usually exhibit a high coercivity and better magnetic stability than multidomain particles. Further reduction in the particle size equates thermal energy to the magnetic anisotropy energy leading to the superparamagnetic state whereby magnetic moments move about swiftly [15]. The role of surface effects is also important as it determines the magnetic behavior on nanoscale. The nanoparticles contain a greater fraction of atoms on surfaces, which have broken symmetry and reduced coordination resulting in changed magnetic interactions. Magnetic anisotropy and saturation magnetization can be affected by surface spin disorder and structural defects thus impacting on the overall magnetic performance of the nanoparticles to be used in biomedical applications. Superparamagnetic phenomenon is especially significant to biomedical fields including targeted drug delivery and magnetic resonance imaging. The SPNPs have a high level of magnetization in the presence of a magnetic field but with zero remanent magnetization once the magnetic field is removed. This reversible magnetism enables the exact outside handling of nanoparticles without aggregation and irreversible magnetization in biological systems [9,14].

Table 1. Magnetic behaviors of materials and their key characteristics

Magnetic Behavior

Magnetic Moment Alignment

Magnetic Susceptibility

Biomedical Relevance

Diamagnetism

Opposes external magnetic field

Very low negative

Minimal

Paramagnetism

Weak alignment with field

Small positive

MRI contrast mechanisms

Ferromagnetism

Strong parallel alignment

High

Limited biomedical use

Ferrimagnetism

Opposite but unequal alignment

Moderate to high

Iron oxide nanoparticles

Superparamagnetism

Single domain fluctuating moment

High

Ideal for drug delivery and imaging

3. Types of Magnetic Nanomaterials Used In Biomedical Applications

Magnetic nanomaterials used in biomedical and pharmaceutical sciences are diverse inorganic and hybrid nanostructures, which have controllable magnetic characteristics and high surface reactivity. These are materials intended to be coupled effectively with biological systems as well as being highly magnetic responsive to the external magnetic fields. The most applied magnetic nanomaterials are iron oxide nanoparticles, ferrite nanoparticles, metallic magnetic nanoparticles, and multifunctional magnetic nanocomposites. The categories have unique magnetic properties, structural stability and biocompatibility profiles, which affect their application in certain biomedical tasks including drug delivery, diagnostic imaging, biosensing and cancer therapy [16]. Saturation magnetization, magnetic anisotropy, chemical stability, surface functionality, and toxicity are some of the parameters that highly determine the selection of magnetic nanomaterial. Among the obtainable magnetic nanomaterials, iron oxide nanoparticles are the ones the most widely studied because of their good safety profile and good magnetic properties. Nevertheless, the recent advancement in nanotechnology has also come up with ferrite-based nanoparticles, metallic magnetic nanoparticles and hybrid magnetic nanocomposites, which have better multifunctional characteristics and better therapeutic performance [17].

3.1 Iron Oxide Nanoparticles

The most noticeable category of magnetic nanomaterials used in biomedical studies is that of iron oxide nanoparticles. These nanoparticles are normally found in two main crystalline forms which include magnetite (Fe 3 O 4 ) and maghemite ( gamma Fe 2 O 3 ). Both forms are ferrimagnetic in bulk form but they exhibit superparamagnetic behavior when produced in nanoscale sizes of less than about twenty nanometers. This is especially beneficial to use in biomedical fields, as it is possible to achieve high magnetic responsiveness in an external field and avoids permanent magnetization of the sample once the field is removed [1,13]. The magnetite nanoparticles have an inverse spinel arrangement structure which is made of Fe 2 and 3 ions that are organized in tetrahedral and octahedral positions. The distinctive structure generates high saturation magnetization induced by the strong magnetic interactions. Maghemite nanoparticles are produced by the oxidation of magnetite and have cation vacancies which preserve a similar spinel structure containing Fe 3 + ions. Both the magnetite and the maghemite nanoparticles exhibit outstanding magnetic characteristics along with the chemical stability under the aqueous conditions hence they can be very useful in biomedical purposes. The use of iron oxide nanoparticles as a contrast agent in magnetic resonance imaging is a well-sketched research topic because iron oxide nanoparticles can vary the proton relaxation time in biological tissues. The superparamagnetic characteristics of them improve the T 2 relaxation signals which allow higher imaging contrast and diagnostic precision. Moreover, therapeutic agents, targeting ligands or polymers can be incorporated on to these nanoparticles in order to develop magnetically directed drug delivery systems that have the ability to deliver drugs to particular tissues in the presence of an external magnetic field [5,14]. Besides imaging and drug delivery, iron oxide nanoparticles were also shown to have a bright future in magnetic hyperthermia therapy. These nanoparticles produce localized heat on exposing them to alternating magnetic fields due to the Néel and Brownian relaxation processes. The resultant thermal energy can selectively trigger either apoptosis or necrosis in cancer cells with minimum harm to the surrounding healthy tissues [6].

Figure 3. Magnetism and crystal structures of iron oxide nanoparticles such as magnetite and maghemite in biomedical applications.

The Figure 3. Demonstrates the crystal structures and magnetic properties of iron oxide nanoparticles that are in common use in biomedical applications. The diagram depicts the spinel structure of the magnetite (Fe 3 O 4 ) and maghemite ( 8-Fe 2 O 3 ), which is ferrimagnetic and superparamagnetic on a nanoscale. Their magnetic characteristics allow them to be used in biomedical practice in targeted drug delivery, magnetic resonance imaging (MRI), and magnetic hyperthermia treatment.

3.2 Ferrite Nanoparticles

Another significant type of magnetic nanomaterials is ferrite nanoparticles with the general chemical formula MFe 2 O 4 where M is a divalent metal ion: cobalt, nickel, zinc, or manganese. These nanoparticles assume spinel crystal structures as that of iron oxide nanoparticles yet they have altered magnetic properties relative to the metal ion incorporated. Various metal cations have an effect on an magnetic anisotropy, saturation magnetization, and magnetic relaxation behavior [17]. Cobalt ferrite nanoparticles are highly anisotropic and coercive in nature and can be used in applications where magnetic properties are needed to remain constant like in magnetic hyperthermia therapy or magnetic data storage. The nanoparticles of ferrite containing nickel exhibit an average magnetic behavior and a good chemical stability that enable them to be used as biosensing and catalytic proteins in biomedical. The nanoparticles of zinc ferrite exhibit comparatively less magnetic anisotropy but have a greater biocompatibility and chemical stability that has prompted the interest in using them in drug delivery and diagnostic imaging systems. The high magnetic anisotropy of ferrite nanoparticles has made them popular in hyperthermia therapy due to their high efficiency in the generation of heat when they are exposed to alternating magnetic fields. Nevertheless, their surface alteration and toxicity should be carefully done and assessed to make their use safe in the biomedical settings because metal ions can be released when they degrade.

3.3 Metallic Magnets Nanoparticles.

Transitional metals of iron, cobalt and nickel are found in metallic magnetic nanoparticles, which have very high saturation magnetization values in comparison to metal oxide-based nanoparticles. Such nanoparticles are highly magnetic-responsive and possess high efficiency on heating in application of magnetic hyperthermia. The large magnetic moment allows them to be further manipulated with external magnetic fields which is useful in targeted drug delivery and in the magnetic separation processes [18]. Although they are very attractive with regard to their magnetism nature, metallic magnetic nanoparticles encounter a number of challenges associated with chemical stability and possible cytotoxicity. Such nanoparticles are very prone to oxidation at the presence of air or aqueous conditions and hence form surface oxide layers which change their magnetic properties. In addition, the direct exposure of biological tissues to metallic nanoparticles could cause oxidative stress and inflammation. To address these drawbacks, metallic magnetic nanoparticles are in most cases coated with protective shell made out of polymers, silica, or carbon building blocks. These protective layers improve chemical stability, prevent oxidation, and biocompatibility as well as high magnetic responsiveness. Encapsulation methods have made it possible to create multifunctional nanoparticles that integrate high magnification of magnets of metal cores, stability, and safety of protective surfaces.

3.4 Magnetic Nanocomposites and Hybrid Nanomaterials.

Magnetic nanocomposites are a new type of multifunctional materials that can be developed by the addition of magnetic nanoparticles to organic/inorganic materials like polymers, silica, gold or carbon-based nanostructures. The following hybrid systems are constructed to incorporate several functional properties in one nanoplatform, and therefore they improve their usage in biomedical and pharmaceutical biomedical use [7]. The magnetic nanocomposites based on polymers are popular in use as drug delivery system due to the fact that polymer matrices are biocompatible, flexible and have the ability to deliver drug in a controlled manner. Polyethylene glycol, chitosan and polycaprolactone are the most common polymers used to coat magnetic nanoparticles to enhance the colloidal stability and extend circulation time in the blood. Magnetic nanoparticles coated with silica have become of significant interest with regard to their superior chemical stability and the ability to be functionalized on their surface easily. The silica shell offers a protective coating that prevents agglomeration of nanoparticles and enables the biomolecule binding, antibodies, peptides and nucleic acids, to be attached to the nanoparticles and therapeutically targeted. Carbon based magnetic nanomaterials such as graphene and carbon nanotube composite are some new hybrid systems with unusual electronic and mechanical characteristics. Such materials provide extensive surface areas to drug loading and have a high potential of biosensing, imaging and photothermal therapy. Nanomedicine Multifunctional magnetic nanocomposites have tremendously increased the scope that magnetic nanomaterials have. These hybrid systems are capable of diagnostic imaging, targeted drug delivery and therapeutic capabilities in parallel and this has resulted in integrated theranostic platforms with the ability to enhance disease diagnosis and treatment efficacy [8].

Table 2. Major categories of magnetic nanomaterials used in biomedical applications

Type of Magnetic Nanomaterial

Example Materials

Key Properties

Major Biomedical Applications

Iron oxide nanoparticles

Fe?O?, γFe?O?

Superparamagnetic, biocompatible

MRI contrast agents, drug delivery

Ferrite nanoparticles

CoFe?O?, NiFe?O?, ZnFe?O?

Tunable magnetic anisotropy

Hyperthermia therapy, biosensing

Metallic nanoparticles

Fe, Co, Ni

High saturation magnetization

Magnetic targeting, hyperthermia

Magnetic nanocomposites

Polymer coated or silica coated nanoparticles

Multifunctional and stable

Theranostics, controlled drug delivery

4. Synthesis Methods of Magnetic Nanomaterials

The magnetic nanomaterials synthesis is important in defining their structural properties, magnetic properties, surface chemistry and biocompatibility. The size, morphology, crystallinity, and surface functionality of nanoparticles can only be optimized by having precise control over particle size, morphology, crystallinity and functionality. During the last several decades, hundreds of synthetic methods have been established in order to obtain magnetic nanoparticles with controlled characteristics that can be used in medical imaging, targeted drug delivery, biosensing, and cancer therapy [19]. In general, magnetic nanomaterials can be produced by three primary methods such as chemical synthesis processes, physical manufacturing processes, as well as biological or green synthesis processes. Chemical methods are the most popular because they are simple to use, scalable and can be used to generate nanoparticles with a size distribution. Physical procedures are very pure and crystalline and can be very energy-demanding and instrument intensive. Recently, the biological and green synthesis methods have become one of the environmentally friendly alternatives that involve using microorganisms, or plant derived compounds to produce biocompatible nanoparticles [20]. Various factors including the desired particle size, magnetic properties, functionality, and biomedical application among others determine the selection of an appropriate synthesis technique. The benefits and drawbacks of each of the synthesis methods are unique, and should be closely taken into account when designing magnetic nanomaterials to be used in a clinical or pharmaceutical context.

4.1 Chemical Synthesis Methods

The most widely used methods of synthesizing magnetic nanoparticles are those involving chemical synthesis because they have rather simple procedures and allow a great deal of control in the size and composition of particles. Co-precipitation, thermal decomposition, hydrothermal synthesis, and sol-gel are also some of the most common methods of synthesizing iron oxide and ferrite nanoparticles [21]. One of the simplest and most commonly used techniques of synthesis of iron oxide nanoparticles is co-precipitation. It is done by the concomitant precipitation of ferrous and ferric ions in an aqueous alkaline solution. Their nucleation and growth will take place when iron salts like FeCl 2 and FeCl 3 are combined in a basic medium leading to the production of magnetites nanoparticles. The reaction parameters such as pH, temperature, ionic concentration, and rate of stirring have a great effect on the size and morphology of nanoparticles. Although co-precipitation method has the advantage of being simple and scaling up, the method typically produces nanoparticles of relatively large size distribution and mediocre crystallinity. Another chemical method that has been extensively utilized that yields highly uniform magnetic nanoparticles with narrow size distributions is thermal decomposition. The organometallic precursors, which are used in this process, include iron acetylacetonate which is decomposed at high temperatures in organic solvents under the influence of the surfactants. The surfactants used include oleic acid and oleylamine which are stabilizing agents that prevent aggregation of nanoparticles and provide the opportunity to control the growth of particles accurately. Thermal decomposition is normally used to obtain very crystalline nanoparticles with high magnetism, but the need of organic solvents, as well as, high reaction temperatures makes the process very complicated and expensive. Hydrothermal synthesis is a chemical reaction which takes place in aqueous solutions but under high temperatures and pressure in closed autoclave reactors. This method facilitates the production of extremely crystalline nanoparticles with regulated morphology and enhanced magnetism. Hydrothermal environment encourages slow and slow growth and nucleation, which are capable of producing nanoparticles that have a well-defined shape, either a sphere, rod or cube. Another chemical process that is employed in the synthesis of magnetic nanomaterials involves sol-gel in which the metal precursors undergo hydrolysis and condensations reactions to form the nanomaterial. During this process, the metal alkoxides or salts are subjected to hydrolysis to generate a colloidal suspension that then gets converted to a gel system. Further drying and heating results in the development of magnetic nanoparticles of controlled composition and uniform dispersion in a solid matrix. Sol-gel technique is especially employed in the production of magnetic nanocomposites and hybrid materials to use in biomedical applications [22].

Figure 4. Diagnostic diagram of frequent chemical synthesis strategies of magnetic nanoparticles such as co-precipitation, thermal decomposition, hydrothermal synthesis and solgel.

The Figure 4, indicates the chemical synthesis methods of the magnetic nanoparticles preparation. The diagram identifies four common methods such as co-precipitation, thermal decomposition, hydrothermal synthesis and sol-gel process all of which exhibit varying reaction conditions as well as reaction mechanisms through which the nanoparticle size, crystallinity and magnetic properties can be established.

4.2 Physical Synthesis Methods

Physical synthesis methods entail the creation of magnetic nanoparticles by mechanical or physical methods which are not based on chemical reactions in solution. The approaches usually produce nanoparticles that are highly pure and crystalline, which is appealing to some of the current technological and biomedical applications [23]. Ball milling is one of the most common examples of physical means and entails the mechanical grinding of bulk magnetic materials into nanoscale particles with high energy milling devices. In this operation, a collusion between the milling balls and the bulk material into smaller nanoscale particles happens repeatedly. The benefit of ball milling is that no elaborate reagents are needed in the process, but, the milling media may leave structural defects and contaminate the product. Another physical method of the synthesized magnetic nanoparticles is laser ablation. In this procedure, the high energy beam of laser is focused on a solid metal target which is placed into a liquid media. The high intensity laser energy melts away minute amounts of the target material to create plasma that quickly cools and condenses to nanoparticles. The benefit of laser ablation is that the method of generating nanoparticle purity is of high merit without any chemical contaminants, but the technology is expensive, and the instrumentation used is both complex and expensive to operate. Physical vapor deposition is another significant physical process in which atoms of metal are vaporized; this is done by vaporizing a solid material, thereafter condensing it onto a substrate to produce structures of nanoscale. Thin films and nanostructured magnetic materials with remarkably controlled composition and thickness have been produced using variants of this technique including sputtering and evaporation. However, physical methods of synthesis have enjoyed benefits of purity and crystallinity and are typically not as common in biomedical applications as chemical methods because of limitations in large scale generation and ability to functionalise the surfaces.

4.3 Green Synthesis and Biological.

The magnetic nanoparticles produced biologically have been receiving growing interest as a sustainable and eco-friendly substitute of traditional chemical and physical procedures. In these methods, biological systems such as microorganisms, plant extracts, and biomolecules are used to promote the formation of nanoparticle using naturally occurring biochemical systems [24]. Microorganisms like the bacteria, fungi and algae have been able to produce magnetic nanoparticles by enzymatic reduction and biomineralization. Some magnetotactic bacteria synthesize magnetic nanoparticles (called magnetosomes) that are magnetite nanoparticles that fulfill the role of internal magnetic sensors and work to orient orient the bacteria within geomagnets. Such biologically synthesized nanoparticles are of a very homogeneous size and have good magnetic properties. Another green method that has potential of manufacturing magnetic nanoparticles involves plant mediated synthesis. Under this technique, plant extracts of phytochemicals (polyphenols, flavonoids and alkaloids) are used as reducing and stabilizing agents in the formation of nanoparticles with metal salts. Plant based synthesis can prove to be quite beneficial in a number of ways such as; it is cheap, eco-friendly and toxic chemical reagents are removed. Biocompatibility: Biologically synthesized magnetic nanoparticles in many ways have increased biocompatibility because of the presence of natural biomolecules on the surfaces of the nanoparticles. These biomolecules make nanoparticles more stable and their ability to interact with biological systems, which is useful in biomedical applications, including drug delivery, biosensing, and imaging. Irrespective of these benefits, biological synthesis procedures continue to have issues associated with reproducibility, scalability, and control of nanoparticle size and morphology. Current studies are striving to streamline these procedures to allow production of high amounts of high quality magnetic nanomaterials that can be used in clinical applications on a large scale.

Table 3. Comparison of major synthesis methods for magnetic nanoparticles

Synthesis Method

Advantages

Limitations

Typical Applications

Co-precipitation

Simple, scalable, low cost

Broad size distribution

Drug delivery, MRI contrast

Thermal decomposition

High crystallinity and uniform size

High temperature and organic solvents

Imaging, hyperthermia

Hydrothermal synthesis

Controlled morphology

Requires high pressure equipment

Catalysis, biomedical materials

Physical methods

High purity nanoparticles

Expensive instrumentation

Magnetic thin films

Biological synthesis

Eco friendly and biocompatible

Limited scalability

Biomedical and pharmaceutical research

5. Surface Functionalization and Modification of Magnetic Nanoparticles

The surface functionalization is one of the most important procedures in the evolution of magnetic nanoparticles in the field of biomedical uses. Even though magnetic nanoparticles have the appropriate magnetic characteristics, their direct application into biological systems is frequently hampered by factors such as aggregation, low colloidal stability, fast elimination by the blood system, and even cytotoxicity. The technologies that are instead used to increase the nanoparticle stability, biocompatibility and targeting ability without altering their magnetic responsiveness are surface modification strategies [25]. Magnetic nanoparticles have many active platforms due to its high surface to volume ratio. Nanoparticles can be functionalized by applying suitable surface engineering such as coating them with polymers, inorganic substances, biomolecules, or targeting ligand to promote their reactivity with a biological environment. These functional surfaces not only help to avoid aggregation of nanoparticles; they also give functional groups where drugs can be loaded, imaging agent, or targeting molecule [26]. The functionalization of surface is also significant in the regulation of pharmacokinetics and biodistribution of the magnetic nanoparticles in body. Hydrophilic and biocompatible molecules can be used to modify the surface of the nanoparticles to avoid recognition by the reticuloendothelial system and increase the time of circulation in the bloodstream. Such prolonged circulation enhances the efficiency of drug delivery and imaging use.

5.1 Polymer Coating

One of the most popular strategies of the magnetic nanoparticles surface modification is the polymer coating. Biocompatible polymers coating the surface of nanoparticles enhance colloidal stability and aggregation prevention of nanoparticles in physiological conditions. Polymer functional groups can also be used to provide functional groups that allow the attachment of a therapeutic agent or targeting ligands. Polyethylene glycol is also one of the polymers that have been extensively employed as a functional group in nanoparticles because of its high biocompatibility and the capacity to inhibit nonspecific adsorption of proteins. Magnetic nanoparticles that have polyethylene glycol coating exhibit an increased level of circulation time in blood owing to the fact that the macrophages of the immune system cannot recognize or absorb the nanoparticles due to the presence of a hydrophilic polymer coating. This is also known as the stealth effect and this greatly enhances the efficacy of the nanoparticle-based drug delivery systems [27]. Chitosan and dextran are some of the naturally occurring polymers that are extensively used in coating magnetic nanoparticles. Chitosan is a biodegradable polysaccharide that is a form of chitin with good biocompatibility and antimicrobial characteristics. Magnetic nanoparticles coated with chitosan demonstrate enhanced stability and are readily functionalized with drugs or nucleic acids to be used in application in gene therapy and delivery of drugs. Dextran coated magnetic nanoparticles have been widely researched in the field of clinical imaging, especially as contrast agents in magnetic resonance imaging. The dextran coating increases the dispersion of the nanoparticles in the aqueous media and predisposes them better to the biological tissues. Moreover, dextran has numerous hydroxyl groups which can further be functionalized chemically.

Figure 5. Diagrammatic representation of a polymer covered magnetic nanoparticle by indicating drug loading and targeting ligand functionality.

The figure 5 shows that the used to denote the polymer-coated magnetic nanoparticles that were intended to be used in targeted delivery of the drugs. The figure depicts that a magnetic nanoparticle core is covered with biocompatible polymers that allow loading of drugs and controlled release, but target ligands, like antibodies, peptides or aptamers are anatomized onto the surface to allow selective binding to particular cells or receptors to make the nanoparticles more therapeutically effective.

5.2 Silica Coating

The other common surface modification technique to use on magnetic nanoparticles is silica coating. Silica shells offer a number of benefits that include chemical stability, biocompatibility, and the ability to functionalize the surface easily. The layer of silica is a protective layer that prevents oxidation and aggregation of nanoparticles and ensures that magnetic particles are responsive. Tetraethyl orthosilicate is usually reacted to silica to create silica coated magnetic nanoparticles during sol gel processes where the silica material is subjected to hydrolysis and condensation reactions to create a silica shell around the magnetic core. The resulting core shell structure results in the combination of the magnetic properties of the core and the chemical stability of the silica shell [28]. The significant benefits of silica coatings include the inclusion of silanol groups on the surface and this is a feature that enables the addition of other functional molecules by using well established silane chemistry. This allows conjugation of fluorescent dyes, drugs, antibodies or nucleic acids to the nanoparticle surface. Consequently, magnetic nanoparticles containing silica have proven to have extensive uses in targeted drug delivery, biosensing and multimodal imaging. Moreover, some silica shells have porous structure, which enables them to carry a high amount of drugs and therefore these nanoparticles can be used in controlled drug release systems. The release of drugs through silica can be controlled by changing the thickness and porosity of silica and enhance the efficacy of the therapy.

5.3 Ligand functionalization and Targeting Molecules.

The functionalization of ligands is a relevant approach to providing magnetic nanoparticles with a certain biological recognition properties. Nanoparticles can be designed to target a particular cell, tissue or biomarker of disease by conjugation with targeting ligands, including antibodies, peptides, or small molecules. This specific interaction goes a long way in improving effectiveness of nanoparticle based diagnostic and therapeutic systems. The targeting ligand commonly is an antibody because of its high specificity with respect to specific antigens on the surface of the cancer cells or the pathogen microorganisms. Antibody-conjugated magnetic nanoparticles can be targeted to diseased tissues and will therefore be useful in delivering therapeutic agents or better imaging contrast. Nanoparticle targeting is also commonly done using peptide based ligands as these are smaller than antibodies and therefore, can penetrate tissues more easily. Some peptides show high affinity to receptors which are overexpressed on cancer cells allowing them to be used to deliver chemotherapy drugs. Folate folic acid receptors are commonly targeted by small molecule ligands like folic acid that is used on cancer cells. Magnetic nanoparticles functionalized with folic acid can be selectively taken up by tumor cells enhancing targeted delivery system specificity and minimizing toxicity effects on normal tissues. Targeting molecules can thus be functionalized on surfaces to create platforms of nanomedicine of high specificity that can detect and bind a specific biological target.

Table 4. Common surface modification materials used for magnetic nanoparticles

Surface Coating Material

Key Properties

Biomedical Applications

Polyethylene glycol

Hydrophilic, stealth effect

Drug delivery, prolonged circulation

Chitosan

Biodegradable, antimicrobial

Gene delivery, drug delivery

Dextran

Biocompatible polysaccharide

MRI contrast agents

Silica

Chemically stable, functionalizable

Imaging, biosensing

Targeting ligands

Specific biological recognition

Targeted therapy

6. Biomedical Applications of Magnetic Nanomaterials

The magnetic nanomaterials have gained a lot of interest in the biomedical and pharmaceutical studies because of their peculiarity to react to the external magnetic field in their interaction with biological systems. These materials are a combination of nanoscale characteristics that include high-surface-areas, manipulable magnetism, and surface-functionalization capabilities that enable them to carry out various functions that include imaging, targeted drug delivery, and therapeutic treatment. Consequently, the magnetic nanoparticles have become powerful agents in nanomedicine and they have greatly enhanced the opportunities of diagnosing and treating several diseases by manipulating them remotely through external magnetic fields [29]. The capability of the magnetic nanoparticles to be manipulated by external magnetic fields is one of the major pros of the magnetic nanoparticles in the context of nanomedicine. This aspect allows them to be accurately controlled in regard to their movement, localization, and therapeutic activity within the body. Also, magnetic nanoparticles may be produced to contain drug, gene or imaging molecules, enabling them to serve as multifunctional nanoplatforms to perform diagnostic and therapeutic functions, commonly known as theragnostic [30]. The magnetic nanomaterials have thus been utilized in the biomedical domain in very many areas such as targeted drug delivery, diagnostic imaging, magnetic hyperthermia cancer treatment, biosensing and regenerative medicine. Nanoparticle engineering further enhanced their performance, safety, and clinical use in further development by continuing to improve their synthesis and surface engineering.

6.1 Magnetic Drug Delivery

One of the most widely researched areas of magnetic nanoparticles application is targeted drug delivery. The traditional drug delivery systems normally lack efficacy in targeting, systemic toxicity and decreased therapeutic efficacies. Magnetic drug delivery systems are trying to address these shortcomings by exploiting the magnetic nanoparticles as carriers, which deliver drugs to precise disease sites with the application of external magnetic fields [31]. In magnetic drug delivery, therapy is introduced through magnetic nanoparticles in which drugs are coated or encapsulated onto the magnetic nanoparticles. On exposure to an external magnetic field through the target tissue, the nanoparticles are magnetically attracted to form a concentration in the target site. This localized drug loaded nanoparticles concentration contributes to the effectiveness of therapeutic action and the decreased exposure of healthy tissues to drugs. Magnetic nanoparticles can also be used to control the release of drugs using a number of stimuli responsive techniques. As an example, localized heating can be raised by the application of alternating magnetic fields, and this heating causes temperature sensitive coating to release drugs. On the same note, PH sensitive polymer-coatings have the ability to deliver drugs in acidic tumor locales, adds an extra targeting specificity. A lot of studies have indicated that magnetic drug delivery systems are effective in cancer, cardiovascular diseases, and neurological disorders treatment. Such systems have enhanced bioavailability of drugs, less dosage, and better therapeutic effects than traditional ways of drug delivery.

Figure 6. Demonstrative diagram of drug delivery through magnetically controlled nanoparticles of magnetically loaded drug delivery via magnetic field and drug-loaded magnetic nanoparticles.

The figure 6, demonstrates that the drug delivery by the magnetic nanoparticles loaded with drug using the magnetic nanoparticles. The nanoparticles are administered throughout the bloodstream and are guided to the target tissue by an external magnet field allowing concentration of nanoparticles in any site and release of drug in the diseased site in a controlled manner and thereby enhancing the therapeutic effect and limiting side effects on the system.

6.2 Magnetic Resonance Imaging (MRI)

The application of magnetic nanoparticles in magnetic resonance imaging, one of the most significant noninvasive diagnostic imaging methods in contemporary medicine has been prevalent as a contrast agent. The magnetic resonance imaging technique gives an in-depth anatomical and functional data of tissues and organs because relaxation of hydrogen nuclei is measured in the presence of a magnetic field [32]. In MRI, superparamagnetic iron oxide nanoparticles are of particular use as T 2 contrast agents. The local magnetic field inhomogeneities formed by these nanoparticles cause all protons in the vicinity of the nanoparticles to transversely relax, leading to a darker signal in MRI images. This provides the increased contrast which can be used to better visualize tissues, tumors and pathological alterations. To enhance the stability and longevity of magnetic nanoparticles that are utilized in MRI, they are frequently coated with biocompatible polymers like dextran or polyethylene glycol. Surface functionalization with targeting ligands also allows selective concentration in a tissue or disease site, enhancing the diagnostic capability. Over the last few years, multifunctional magnetic nanoparticles have been designed that have imaging as well as therapeutic properties. Such theranostic nanoparticles enable the diagnosis of a disease and its treatment simultaneously, and this is an important step towards personalized medicine.

6.3 Magnetically Resonance Hyperthermia in the Treatment of Cancer.

Magnetic hyperthermia is a new method of treatment of cancer, where magnetic nanoparticles are used to produce local heat in the tumor tissue. The magnetic nanoparticles generate thermal energy when subjected to an alternating magnetic field by magnetic relaxation process. The heat generated by the magnetic nanoparticles raises the temperature of the tumor environment usually to around forty two to forty five degrees Celsius which is sufficient to cause the death of cancer cells without destroying the surrounding normal tissues [33]. The efficiency of the heating effect of the magnetic nanoparticles depends on a number of factors such as, particle size, magnetic anisotropy, saturation magnetization, and frequency of the applied magnetic field. The nanoparticles of iron oxide are widely utilized in the process of hyperthermia therapy due to their proper magnetic characteristics and satisfactory biocompatibility. Magnetic hyperthermia may also be used in conjunction with other traditional cancer therapies like chemotherapy and radiotherapy to improve the efficacy of the therapy. Nanoparticles can be useful in enhancing the effect of treatment by heating the tumors locally, making them more sensitive to chemotherapy drugs and radiations. Even a number of clinical trials have proved that magnetic hyperthermia can treat tumor types like glioblastoma and prostate cancer. On-going studies are trying to optimize the parameters of nanoparticle design and treatment with the objective of increasing the safety and utility of this promising treatment mode.

Figure 7. Mechanism of magnetic hyperthermia showing heat generation from magnetic nanoparticles under an alternating magnetic field.

6.4 Biosensing and Diagnostics

The magnetic nanoparticles have also found extensive use in biosensing and diagnostic devices because of their magnetic responsiveness and capacity of interacting with the biological molecules. Biosensors based on magnetic nanoparticles have high sensitivity and specificity in detecting biomolecules like proteins, DNA, pathogen and disease biomarkers [34]. Nanoparticles used in magnetic biosensing systems are functionalized by a particular recognition molecule of the antibody or nucleic acid. When the nanoparticles are bound to target biomolecules, it leads to an observable alteration in magnetic or optical signal which can be detected and quantified to the target analyte. Magnetic nanoparticles are also applied in magnetic separation techniques, in which they specifically target biological targets and can then be easily separated off complex biological samples with external magnets. This method is common in diagnostic tests, isolating cells, and detection of pathogens. The combination of magnetic nanoparticles with microfluidic devices and biosensor technologies has also promoted the creation of fast and portables diagnostics. These technologies could be of great use in early disease detection and point of care diagnostic uses.

6.5 Tissue Engineering and Regenerative Medicine.

Magnetic nanomaterials are the new materials with potential to be used in the field of tissue engineering and regenerative medicine. The goals of these areas are to restore or substitute injured tissues by using biomaterials, stem cells and bioactive molecules. These processes can be improved with the help of magnetic nanoparticles that allow manipulating and stimulating cells with external magnetic fields [35]. Magnetic nanoparticles may either be embedded into the scaffold in tissue engineering, or directly endocytosed by the cells. It is then possible to drive macroscopic cellular organization, induce tissue growth or modulate cellular signaling events in tissue repair using external magnetic fields. Growth factors and genes that induce tissue repair and cell differentiation have also been delivered using magnetic nanoparticles. Moreover, magnetically respondsive scaffolds enable cell behaviors to be stimulated remotely, which could also affect cell behavior and enhance tissue formation. Such properties render magnetic nanomaterials very appealing in regenerative medicine studies like bone repair, cartilage repair and neural tissue engineering. The future use of magnetic nanoparticles in regenerative therapy is set to be extended due to further progress of nanotechnology and biomaterials science.

7. Nano-Particles of Magnets Have A Toxicity and Bio Compatibility.

Despite the outstanding potential of magnetic nanoparticles under biomedical and pharmaceutical studies, toxicity and long-term safety concerns are of relevance as far as clinical translation is concerned. The biological systems react with the nanoparticles in a complicated manner and tend to vary on various factors such as the size, shape, chemical composition, surface charge, and surface coating. The above physicochemical properties have a profound effect on cellular uptake, biodistribution, metabolism, and elimination of nanoparticles in the body [36]. The biocompatibility is a factor that describes the capability of a material to accomplish its desired biological purpose without causing adverse reactions to adjacent tissues. In the case of magnetic nanoparticles as a medical tool, high biocompatibility should be achieved to reduce the negative biological reactions like inflammation, oxidative stress, or cytotoxicity. This means that a lot of in vitro and in vivo research is needed to determine the safety profiles of magnetic nanomaterials before they can be used in clinical environment. Iron oxide nanoparticles have been the most studied nanoparticle because they have a fairly good safety profile as compared to other metallic nanoparticles. Once introduced into the body, these nanoparticles may be metabolized in the normal iron metabolic pathways with the incorporation of iron ions into hemoglobin or into ferritin related proteins. Nonetheless, overloading of some organs like liver, spleen or lungs can cause toxicity in case the nanoparticles are not regulated effectively [37].

7.1 Factors Affecting the Nanoparticle Toxicity.

Magnetic nanoparticles exhibit high toxicity and certain physicochemical parameters play a strong role that dictates the interaction of nanoparticles with biological systems. Of these factors, the particle size is one of the most important factors in cellular uptake and biodistribution. The smaller nanoparticles tend to be highly internalized by the cells because they find it easier to penetrate the biological barriers. Nano-particles however, very minute in size can also enter very sensitive tissues like the blood-brain barrier, and this may have unexpected biological consequences. The other factor that has a significant effect on the toxicity of nanoparticles is surface charge. The positively charged nanoparticles are likely to exhibit a high affinity towards negatively charged cell membranes and can result in elevated levels of cellular uptake but can also destabilize the membrane integrity and lead to cytotoxic effects. Conversely, neutral or even negative surface charges tend to lead to a higher biocompatibility and decreased nonspecific binding with biological elements. Another factor that influences the toxicity profiles of the nanoparticles is chemical composition and crystallinity. Metallic nanoparticles like cobalt or nickel can also produce toxic metal ions in degradation pathways and these have the potential to cause oxidative stress and inflammation. Conversely, iron oxide nanoparticles tend to be of lower toxicity due to the ability of the iron ions to be assimilated into body natural metabolism processes. The techniques of surface coating and functionalization can play an important role in the safety of nanoparticles as they prevent aggregation, decrease nonspecific adsorption of proteins, and enhance stability in physiological environment. Proper surface modification is thus a necessary measure towards reducing toxicity and increasing clinical potential of magnetic nanomaterials [38].

7.2 Cellular Uptake and Biodistribution.

After magnetic nanoparticles are introduced into the body, they interact with biological fluids and proteins resulting in a protein corona being formed on the nanoparticle surface. The presence of this layer of protein affects cellular recognition and uptake of nanoparticles. Reticuloendothelial system macrophages contribute significantly to the elimination of nanoparticles in the blood through phagocytosis and their concentration in the body will mainly appear in the liver and spleen. Magnetic nanoparticles can be cellularly uptaken in a number of ways such as endocytosis, phagocytosis and receptor mediated internalization. The route of uptake varies and is dependent on the size of nanoparticles, surface chemistry, and cell type. After entering the body, the nanoparticles are usually carried to the endosomal and lysosomal sites and can be degraded. Research on biodistribution has demonstrated that magnetic nanoparticles will be concentrated in the organs which are linked to the reticuloendothelial system. Although, this property is useful in imaging and treatment of some diseases including liver tumors, excess accumulation can cause long term toxicity when nanoparticles are not metabolized or excreted effectively [38].

7.3 Strategies to Improve Biocompatibility

A number of strategies have been designed to enhance the biocompatibility of the magnetic nanoparticles in order to guarantee the safe use of the biomedical applications. The surface coating of biocompatible polymers like polyethylene glycol, dextran, or chitosan is very common so as to minimize immune responses and enhance stability of nanoparticles in physiological context. These surfaces also inhibit aggregation and ensure that direct contact between the nanoparticle core and the biological tissues is inhibited. The size of nanoparticles and surface charge is another critical approach to reduce toxicity. Nanoparticles with size of about ten to one hundred nanometers are usually viewed as the ideal size to use in biomedical applications due to their efficient cellular uptake and avoidance of rapid clearance by the kidneys or excessive tissue deposition in the body. Nanoparticles can also be targeted against diseased tissues with the help of targeting ligands, which results in reduced nonspecific uptake throughout the body. Targeted delivery does not only enhance the therapeutic performance, but it minimizes possible side effects of exposure to the systemism. Another possible solution to enhancing safety is biodegradable magnetic nanoparticles. Such nanoparticles are set to break down in non-toxic substances that are exertable through natural metabolic routes. Further investigations in nanoparticle engineering are seeking to come up with magnetic nanomaterials with a better safety profile to be used in long term biomedical applications [39].

8. Weaknesses and Opportunities.

Regardless of the tremendous growth observed in the formation of magnetic nanomaterials to biomedical use, there are still a number of challenges that restrict penetration of their application in clinical practice. These difficulties are based on the problems of nanoparticle production, biological experience, safety, and regulation issues. The limitation is important to overcome in order to make the magnetic nanoparticle-based technologies to move out of the laboratory research to actual medical practice. The primary issue is that in large scale synthesis, it is difficult to attain an accurate control of nanoparticle size, shape, and magnetic properties. Nanoparticles with high properties can be readily produced by a variety of laboratory scale synthesis methods, but it is hard to scale the methods to industrial production with any consistency in quality. The differences in the characteristics of nanoparticles may have a great impact on their biological behavior, therapeutic efficacy, and safety profile. The other issue of concern is the complexity of interactions of nanoparticles in a biological setting. As the magnetic nanoparticles gain entry into the body, they are met with proteins, cells and biological barriers which affect their distribution and functionality. Targeting ability and biological activity of nanoparticle surfaces can be altered by the formation of a protein corona on the nanoparticle surface. These interactions are still under investigation and their management is an active field of nanomedicine research. Biocompatibility and long term toxicity also continue to be a concern. Though iron oxide nanoparticles can be regarded as comparatively safe, long time deposits in the body organs like liver or spleen can cause possible adverse outcomes. Proper investigations must be conducted on the long term fate, metabolism, and clearance of magnetic nanoparticles in the body of a human being. Moreover, the use of nanoparticle based medical technologies has to undergo a thorough safety assessment and standard testing procedures, before being approved by the regulations. It is believed that future studies in magnetic nanomaterials will be done towards development of multifunctional nanoparticles that can be able to carry out multiple biomedical functions at a given time. The subsequent generation nanoplatforms will have the capability to combine diagnostic imaging, targeted drug delivery, and therapy functions on a single platform. These types of integrated systems are often termed as theranostic nanoparticles and can be of great potential to personalized medicine. With the development of nanotechnology, materials science, and biotechnology, it is likely that highly sophisticated magnetic nanomaterials with better targeting capacity, increased therapeutic efficacy, and reduced toxicity will be designed. The recent developments of stimulus responsive nanoparticles, biodegradable magnetic nanomaterials and artificial intelligence-directed nanoparticle design have the potential to further boost the advancement in this sector. As interdisciplinary research and technology continue to advance, magnetic nanomaterials should be able to contribute more to the progress of biomedical science and clinical medicine in the future [40].

CONCLUSION

Magnetic nanomaterials have become one of the most promising types of material used in the vast variety of biomedical and pharmaceutical practices. They are distinguished by their magnetic properties, their dimensions in the nanoscale, and a wide range of surface chemistry which allows them to perform tasks that cannot be done using traditional materials. Recent developments in synthesis methods, surfaces and functionalizations, and nanomedicine have shown that magnetic nanoparticles have enormous potential in the fields of targeted drug delivery, diagnostic imaging, cancer treatment using magnetic hyperthermia, biosensing, and tissue engineering of the numerous magnetic nanomaterials, the iron oxide nanoparticles are the most studied considering their desirable magnetic characteristics and its relative biocompatibility. The creation of state-of-the-art magnetic nanocomposites and hybrid nanostructures has enabled the functional capabilities of these materials to be extended further to enable the integration of diagnostic and therapeutic capability in the same nanoplatform. Nevertheless, there are a few issues yet to be resolved before magnetic nanomaterials can be used in a widespread clinical environment. Problems associated with the nanoparticle toxicity, long-term safety, biodistribution and large scale production are to be explored. The structure of nanoparticles, surface coating and targeting methods will have to be well designed so as to enhance their safety and efficacy in biomedical settings. All in all, the magnetic nanomaterials are a highly developing sphere that has enormous opportunities to change the modern medicine. The successful implementation of magnetic nanotechnology in healthcare systems of the future will be ensured by developing a more nano-technology-based design, getting to know more about biological interactions, and ensuring safety in nanoparticles.

REFERENCE

  1. Pankhurst QA, Connolly J, Jones SK, Dobson JJ. Applications of magnetic nanoparticles in biomedicine. Journal of physics D: Applied physics. 2003 Jul 7;36(13):R167-81.
  2. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chemical reviews. 2008 Jun 11;108(6):2064-110.
  3. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. biomaterials. 2005 Jun 1;26(18):3995-4021.
  4. Berry CC, Curtis AS. Functionalisation of magnetic nanoparticles for applications in biomedicine. Journal of physics D: Applied physics. 2003 Jul 7;36(13):R198-206.
  5. Jun YW, Lee JH, Cheon J. Chemical design of nanoparticle probes for high?performance magnetic resonance imaging. Angewandte Chemie International Edition. 2008 Jun 27;47(28):5122-35.
  6. Jordan A, Scholz R, Wust P, Fähling H, Felix R. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. Journal of Magnetism and Magnetic materials. 1999 Jul 1;201(1-3):413-9.
  7. Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Advanced drug delivery reviews. 2008 Aug 17;60(11):1252-65.
  8. Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. Magnetic nanoparticles for drug delivery. Nano today. 2007 Jun 1;2(3):22-32.
  9. Tartaj P, del Puerto Morales M, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ. The preparation of magnetic nanoparticles for applications in biomedicine. Journal of physics D: Applied physics. 2003 Jul 7;36(13):R182-97.
  10. Dobson J. Magnetic nanoparticles for drug delivery. Drug development research. 2006 Jan;67(1):55-60.
  11. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chemical reviews. 2012 Apr 11;112(4):2323-38.
  12. Hergt R, Dutz S. Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy. Journal of Magnetism and Magnetic Materials. 2007 Apr 1;311(1):187-92.
  13. Colombo M, Carregal-Romero S, Casula MF, Gutiérrez L, Morales MP, Böhm IB, Heverhagen JT, Prosperi D, Parak WJ. Biological applications of magnetic nanoparticles. Chemical Society Reviews. 2012;41(11):4306-34.
  14. Lee N, Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chemical Society Reviews. 2012;41(7):2575-89.
  15. Thanh NT, Maclean N, Mahiddine S. Mechanisms of nucleation and growth of nanoparticles in solution. Chemical reviews. 2014 Aug 13;114(15):7610-30.
  16. Wu W, He Q, Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale research letters. 2008 Oct 2;3(11):397.
  17. Lu AH, Salabas EE, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angewandte chemie international edition. 2007 Feb 12;46(8):1222-44.
  18. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine. 2007 Feb 1;2(1):23-39.
  19. Park J, An K, Hwang Y, Park JG, Noh HJ, Kim JY, Park JH, Hwang NM, Hyeon T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nature materials. 2004 Dec 1;3(12):891-5.
  20. Thanh NT, Green LA. Functionalisation of nanoparticles for biomedical applications. Nano today. 2010 Jun 1;5(3):213-30.
  21. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE transactions on magnetics. 1981 Mar 31;17(2):1247-8.
  22. Brinker CJ, Scherer GW. Sol-gel science: the physics and chemistry of sol-gel processing. Gulf Professional Publishing; 1990 Apr 28.
  23. Amendola V, Meneghetti M. Laser ablation synthesis in solution and size manipulation of noble metal nanoparticles. Physical chemistry chemical physics. 2009;11(20):3805-21.
  24. Iravani S. Green synthesis of metal nanoparticles using plants. Green chemistry. 2011;13(10):2638-50.
  25. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-760.
  26. Siafaka PI, Üstünda? Okur N, Karavas E, Bikiaris DN. Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses. International journal of molecular sciences. 2016 Aug 31;17(9):1440.
  27. Mazdaei M, Asare-Addo K. A mini-review of nanocarriers in drug delivery systems. British journal of pharmacy. 2022 Jun 1;7(1):1-3.
  28. Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan W. Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir. 2001 May 15;17(10):2900-6.
  29. Estelrich J, Busquets MA. Iron oxide nanoparticles in photothermal therapy. Molecules. 2018 Jun 28;23(7):1567.
  30. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature materials. 2013 Nov;12(11):991-1003.
  31. Shubayev VI, Pisanic II TR, Jin S. Magnetic nanoparticles for theragnostics. Advanced drug delivery reviews. 2009 Jun 21;61(6):467-77.
  32. Wahajuddin N, Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. International journal of nanomedicine. 2012 Jul 6:3445-71.
  33. Day NB. Delivery of Cancer Immunotherapies Using Engineered Particle Systems (Doctoral dissertation, University of Colorado at Boulder).
  34. Cortade DL. Giant Magnetoresistive Biosensors for Point-of-Care and Personalized Pain Medicine. Stanford University; 2022.
  35. Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of functionalized magnetic nanoparticles. Journal of bioscience and bioengineering. 2005 Jul 1;100(1):1-1.
  36. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. science. 2006 Feb 3;311(5761):622-7.
  37. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chemical reviews. 2012 Apr 11;112(4):2323-38.
  38. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nano-enabled medical applications. 2020 Nov 23:205-29.
  39. Fadeel B, Farcal L, Hardy B, Vázquez-Campos S, Hristozov D, Marcomini A, Lynch I, Valsami-Jones E, Alenius H, Savolainen K. Advanced tools for the safety assessment of nanomaterials. Nature nanotechnology. 2018 Jul;13(7):537-43.
  40. Wang YX. Superparamagnetic iron oxide-based MRI contrast agents: Current status of clinical application. Quantitative imaging in medicine and surgery. 2011 Dec;1(1):35.

Reference

  1. Pankhurst QA, Connolly J, Jones SK, Dobson JJ. Applications of magnetic nanoparticles in biomedicine. Journal of physics D: Applied physics. 2003 Jul 7;36(13):R167-81.
  2. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chemical reviews. 2008 Jun 11;108(6):2064-110.
  3. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. biomaterials. 2005 Jun 1;26(18):3995-4021.
  4. Berry CC, Curtis AS. Functionalisation of magnetic nanoparticles for applications in biomedicine. Journal of physics D: Applied physics. 2003 Jul 7;36(13):R198-206.
  5. Jun YW, Lee JH, Cheon J. Chemical design of nanoparticle probes for high?performance magnetic resonance imaging. Angewandte Chemie International Edition. 2008 Jun 27;47(28):5122-35.
  6. Jordan A, Scholz R, Wust P, Fähling H, Felix R. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. Journal of Magnetism and Magnetic materials. 1999 Jul 1;201(1-3):413-9.
  7. Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Advanced drug delivery reviews. 2008 Aug 17;60(11):1252-65.
  8. Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. Magnetic nanoparticles for drug delivery. Nano today. 2007 Jun 1;2(3):22-32.
  9. Tartaj P, del Puerto Morales M, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ. The preparation of magnetic nanoparticles for applications in biomedicine. Journal of physics D: Applied physics. 2003 Jul 7;36(13):R182-97.
  10. Dobson J. Magnetic nanoparticles for drug delivery. Drug development research. 2006 Jan;67(1):55-60.
  11. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chemical reviews. 2012 Apr 11;112(4):2323-38.
  12. Hergt R, Dutz S. Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy. Journal of Magnetism and Magnetic Materials. 2007 Apr 1;311(1):187-92.
  13. Colombo M, Carregal-Romero S, Casula MF, Gutiérrez L, Morales MP, Böhm IB, Heverhagen JT, Prosperi D, Parak WJ. Biological applications of magnetic nanoparticles. Chemical Society Reviews. 2012;41(11):4306-34.
  14. Lee N, Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chemical Society Reviews. 2012;41(7):2575-89.
  15. Thanh NT, Maclean N, Mahiddine S. Mechanisms of nucleation and growth of nanoparticles in solution. Chemical reviews. 2014 Aug 13;114(15):7610-30.
  16. Wu W, He Q, Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale research letters. 2008 Oct 2;3(11):397.
  17. Lu AH, Salabas EE, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angewandte chemie international edition. 2007 Feb 12;46(8):1222-44.
  18. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine. 2007 Feb 1;2(1):23-39.
  19. Park J, An K, Hwang Y, Park JG, Noh HJ, Kim JY, Park JH, Hwang NM, Hyeon T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nature materials. 2004 Dec 1;3(12):891-5.
  20. Thanh NT, Green LA. Functionalisation of nanoparticles for biomedical applications. Nano today. 2010 Jun 1;5(3):213-30.
  21. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE transactions on magnetics. 1981 Mar 31;17(2):1247-8.
  22. Brinker CJ, Scherer GW. Sol-gel science: the physics and chemistry of sol-gel processing. Gulf Professional Publishing; 1990 Apr 28.
  23. Amendola V, Meneghetti M. Laser ablation synthesis in solution and size manipulation of noble metal nanoparticles. Physical chemistry chemical physics. 2009;11(20):3805-21.
  24. Iravani S. Green synthesis of metal nanoparticles using plants. Green chemistry. 2011;13(10):2638-50.
  25. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-760.
  26. Siafaka PI, Üstünda? Okur N, Karavas E, Bikiaris DN. Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses. International journal of molecular sciences. 2016 Aug 31;17(9):1440.
  27. Mazdaei M, Asare-Addo K. A mini-review of nanocarriers in drug delivery systems. British journal of pharmacy. 2022 Jun 1;7(1):1-3.
  28. Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan W. Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir. 2001 May 15;17(10):2900-6.
  29. Estelrich J, Busquets MA. Iron oxide nanoparticles in photothermal therapy. Molecules. 2018 Jun 28;23(7):1567.
  30. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature materials. 2013 Nov;12(11):991-1003.
  31. Shubayev VI, Pisanic II TR, Jin S. Magnetic nanoparticles for theragnostics. Advanced drug delivery reviews. 2009 Jun 21;61(6):467-77.
  32. Wahajuddin N, Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. International journal of nanomedicine. 2012 Jul 6:3445-71.
  33. Day NB. Delivery of Cancer Immunotherapies Using Engineered Particle Systems (Doctoral dissertation, University of Colorado at Boulder).
  34. Cortade DL. Giant Magnetoresistive Biosensors for Point-of-Care and Personalized Pain Medicine. Stanford University; 2022.
  35. Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of functionalized magnetic nanoparticles. Journal of bioscience and bioengineering. 2005 Jul 1;100(1):1-1.
  36. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. science. 2006 Feb 3;311(5761):622-7.
  37. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chemical reviews. 2012 Apr 11;112(4):2323-38.
  38. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nano-enabled medical applications. 2020 Nov 23:205-29.
  39. Fadeel B, Farcal L, Hardy B, Vázquez-Campos S, Hristozov D, Marcomini A, Lynch I, Valsami-Jones E, Alenius H, Savolainen K. Advanced tools for the safety assessment of nanomaterials. Nature nanotechnology. 2018 Jul;13(7):537-43.
  40. Wang YX. Superparamagnetic iron oxide-based MRI contrast agents: Current status of clinical application. Quantitative imaging in medicine and surgery. 2011 Dec;1(1):35.

Photo
Amruta Kadam
Corresponding author

Asst. Prof., Smt Kashibai Navale College of Engineering, Pune, Maharashtra, India

Photo
Amit Bagade
Co-author

Asst. Prof., Department of Sciences and Humanities, Kasegaon Education Societys Rajarambapu Institute of Technology, Sakharale, Islampur, Sangli, Maharashtra, India

Amruta Kadam*, Amit Bagade, Magnetic Nanomaterials for Biomedical and Pharmaceutical Applications: Fundamentals, Functionalization, and Therapeutic Potential, Int. J. Sci. R. Tech., 2026, 3 (2), 191-210. https://doi.org/10.5281/zenodo.18932010

Related Articles
Method Development and Validation for the Simultaneous Estimation of Esomeprazol...
Nikhil Gupta, Archana Tiwari, Ravinder Kaur, P. K. Dubey, ...
Formulation and Evaluation of Natural Lipstick from Delonix Regia...
Shailesh Solanke , Vaibhav Gunjkar, Mayur Bhosale, ...
Formulation and Evaluation Fast Disintegrating Tablet of Telmisartan...
Harshal Gosavi, Dr. Avish Maru, Jayshri Bhadane, ...
An Approach for Analysis of Marketed Hair Oils as Per Bureau of Indian Standards...
Dr. K. G. Parthiban, A. Ajaykumar, S. Anandharaj, P. Anusiya, P. Arigarasudhan, M. Kalpana Devi, ...